텍사스의 척수성 근위축증 임상 시험
척수성 근위축증 관련 연구 10개가 텍사스 내 여러 지역에서 참여자를 모집하고 있습니다.
텍사스의 도시
공식 연구 텍스트(영어)
A Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Participants With Spinal Muscular Atrophy After Gene Therapy
- The University of Texas Southwestern Medical Center at Dallas, Dallas
- Cook Children's Jane and John Justin Neurosciences Center, Fort Worth
피험자 모집 중4상
3 Months – 24 Months · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT05861986A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy
- University of Texas Southwestern Medical Center, Dallas
- Neurology Rare Disease Center, Flower Mound
- Cook Children's Medical Center, Fort Worth
- 외 1개
피험자 모집 중2상
2세 이하 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT07047144A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
- Neurology Rare Disease Center, Flower Mound
- Texas Children's Hospital, Houston
피험자 모집 중2상
5세 ~ 17세 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT07287982A Study Evaluating the Effectiveness and Safety of Risdiplam Administered in Pediatric Patients With Spinal Muscular Atrophy Who Experienced a Plateau or Decline in Function After Gene Therapy
- University of Texas Southwestern Medical Center, Dallas
피험자 모집 중4상
3 Months – 24 Months · 모든 성별 · 2026. 9. 10. 업데이트됨 · NCT05861999A Study to Find Out How Nusinersen is Processed in the Body When Given Through the ThecaFlex DRx™ System in Adult and Pediatric Participants With Spinal Muscular Atrophy (PIERRE-PK)
- Texas Childrens Hospital Houston, Houston
피험자 모집 중1상
3세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT06555419Study of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular Atrophy
- Texas Children's Hospital, Houston
피험자 모집 중
3세 이상 · 모든 성별 · 2026. 8. 19. 업데이트됨 · NCT05866419A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)
- Neurology Rare Disease Center, Flower Mound
피험자 모집 중3상
0 Days – 42 Days · 모든 성별 · 2026. 8. 18. 업데이트됨 · NCT07221669A Study to Learn About the Safety and Effects of Salanersen (BIIB115) When Given to Babies With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene Abeparvovec
- Neurology Rare Disease Center, Flower Mound
피험자 모집 중3상
0 Days – 7 Months · 모든 성별 · 2026. 8. 11. 업데이트됨 · NCT07444450Clinical Procedures to Support Research in ALS
- University of Texas San Antonio Health Science Center, San Antonio
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 6. 15. 업데이트됨 · NCT03489278Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
- Cook Children's, Fort Worth
- Texas Children's Hospital, Houston
- CHRISTUS Health, San Antonio
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2025. 1. 31. 업데이트됨 · NCT04174157ClinicalTrials.gov 출처, 2026. 10. 5. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.